-
ACAD Dashboard
- Financials
- Filings
-
Holdings
- Transcripts
- ETFs
- Insider
- Institutional
- Shorts
ACADIA Pharmaceuticals (ACAD)
Company Profile
Quarter (USD) | Sep 24 | Mar 24 | Dec 23 | Sep 23 | |
---|---|---|---|---|---|
Revenue | |||||
Cost of revenue | |||||
Operating income | |||||
Operating margin | |||||
Net income | |||||
Net profit margin | |||||
Cash on hand | |||||
Change in cash | |||||
Diluted EPS |
Annual (USD) | Dec 23 | Dec 22 | Dec 21 | Dec 20 | |
---|---|---|---|---|---|
Revenue | |||||
Cost of revenue | |||||
Operating income | |||||
Operating margin | |||||
Net income | |||||
Net profit margin | |||||
Cash on hand | |||||
Change in cash | |||||
Diluted EPS |
Cash burn rate (est.) | Burn method: Change in cash | Burn method: Operating income | Burn method: FCF (opex + capex) | Last Q | Avg 4Q | Last Q | Avg 4Q | Last Q | Avg 4Q |
---|---|---|---|---|---|---|
Cash on hand (at last report) | 163.92 mm | 163.92 mm | 163.92 mm | 163.92 mm | 163.92 mm | 163.92 mm |
Cash burn (monthly) | 15.53 mm | (no burn) | (no burn) | (no burn) | 890.00 k | (no burn) |
Cash used (since last report) | 43.37 mm | n/a | n/a | n/a | 2.48 mm | n/a |
Cash remaining | 120.55 mm | n/a | n/a | n/a | 161.43 mm | n/a |
Runway (months of cash) | 7.8 | n/a | n/a | n/a | 181.4 | n/a |
13F holders | Current |
---|---|
Total holders | 263 |
Opened positions | 74 |
Closed positions | 36 |
Increased positions | 88 |
Reduced positions | 68 |
13F shares | Current |
---|---|
Total value | 2.56 tn |
Total shares | 160.70 mm |
Total puts | 257.30 k |
Total calls | 722.80 k |
Total put/call ratio | 0.4 |
Largest owners | Shares | Value |
---|---|---|
Baker Bros. Advisors | 42.88 mm | $696.77 bn |
Vanguard | 13.71 mm | $222.82 bn |
RTW Investments | 13.71 mm | $222.75 bn |
BLK BlackRock | 12.06 mm | $196.01 bn |
STT State Street | 5.80 mm | $94.26 bn |
Point72 Asset Management | 3.71 mm | $60.29 bn |
Millennium Management | 2.94 mm | $47.74 bn |
D. E. Shaw & Co. | 2.93 mm | $47.69 bn |
Geode Capital Management | 2.84 mm | $46.24 bn |
Marshall Wace | 2.77 mm | $45.08 bn |
Date | Owner | Security | Transaction | Code | Indirect | 10b5-1 | $Price | #Shares | $Value | #Remaining |
---|---|---|---|---|---|---|---|---|---|---|
9 Dec 24 | Thomas Garner | RSU Common Stock | Grant | Acquire A | No | No | 0 | 45,372 | 0.00 | 45,372 |
9 Dec 24 | Thomas Garner | Stock Option Common Stock | Grant | Acquire A | No | No | 18.76 | 235,849 | 4.42 mm | 235,849 |
19 Nov 24 | Mark C. Schneyer | Common Stock | Sell | Dispose S | No | Yes | 16.81 | 10,259 | 172.45 k | 53,302 |
19 Nov 24 | James Kihara | Common Stock | Sell | Dispose S | No | Yes | 16.81 | 4,073 | 68.47 k | 19,863 |
19 Nov 24 | Brendan Teehan | Common Stock | Sell | Dispose S | No | Yes | 16.81 | 10,329 | 173.63 k | 62,105 |
17 Nov 24 | Mark C. Schneyer | Common Stock | Option exercise | Acquire M | No | No | 0 | 9,913 | 0.00 | 63,561 |
17 Nov 24 | Mark C. Schneyer | Common Stock | Option exercise | Acquire M | No | No | 0 | 9,913 | 0.00 | 53,648 |
17 Nov 24 | Mark C. Schneyer | RSU Common Stock | Option exercise | Dispose M | No | No | 0 | 9,913 | 0.00 | 9,913 |
17 Nov 24 | Mark C. Schneyer | RSU Common Stock | Option exercise | Dispose M | No | No | 0 | 9,913 | 0.00 | 9,913 |
17 Nov 24 | James Kihara | Common Stock | Option exercise | Acquire M | No | No | 0 | 3,965 | 0.00 | 23,936 |